The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life threatening conditions. The Aethlon ADAPT system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier, a device with broad spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non government research organizations, the Hemopurifier is also a leading broad spectrum treatment candidate to address bioterror and pandemic threats.
Quote | Aethlon Medical Inc. (NASDAQ:AEMD)
Last: | $0.4505 |
---|---|
Change Percent: | -4.95% |
Open: | $0.42 |
Close: | $0.4505 |
High: | $0.474902 |
Low: | $0.41 |
Volume: | 1,330,483 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Aethlon Medical Inc. (NASDAQ:AEMD)
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
2024-06-27 18:37:05 ET Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Conference Call June 27, 2024, 04:30 PM ET Company Participants Michael Miller - Rx Communications, IR James Frakes - Interim CEO and CFO Steven LaRosa - Chief Medical Officer Conference C...
Message Board Posts | Aethlon Medical Inc. (NASDAQ:AEMD)
Subject | By | Source | When |
---|---|---|---|
$AEMD Aethlon Medical Inc | mick | investorshub | 04/30/2023 11:11:18 PM |
Choo choo play as they want the chase. $AEMD mb | Mt. Blanc | investorshub | 04/21/2023 12:14:19 PM |
I can't find any major news today on | twogreen2c | investorshub | 04/20/2023 2:22:53 PM |
IMO : ONE WORD | power11 | investorshub | 04/20/2023 2:20:13 PM |
$AEMD Aethlon Medical Inc | mick | investorshub | 04/15/2023 3:19:13 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...